Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajpal Singh Kochhar05-04-2017
05-04-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aresko Progressive Pvt Ltd05-04-2017
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aresko Progressive Pvt Ltd04-04-2017
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajpal Singh Kochhar03-04-2017
Revised Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the revised disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aresko Progressive Pvt Ltd24-03-2017
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajpal Singh Kochhar24-03-2017
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aresko Progressive Pvt Ltd24-03-2017
Resignation of Director
Jagsonpal Pharmaceuticals Ltd has informed BSE that Dr. Surinder Kumar Goyal, Director has resigned from Directorship of the Company w.e.f. February 14, 2017, his resignation has been approved by the Board of Directors in their meeting held on February 14, 2017. (Copy of resignation & resolution is enclosed).15-02-2017
Standalone Financial Results, Limited Review Report for December 31, 2016
Jagsonpal Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 201614-02-2017
Outcome of Board Meeting
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2017, has:- Resignation form Dr. S. K. Goyal was received and accepted by Board of Directors.The meeting commenced at 12.00 noon and concluded at 2.35 p.m.14-02-2017